AzTrials
AzTrials

Borderline Personality DisorderPhase 2ADOLIMISNCT03209102

Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder

A Phase 2 study testing Clinical assessment, Stress elicitation experiment and Structural and Functional MRI in people with Borderline Personality Disorder and Adolescent Development, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study aims to better understand the behavioral, neurobiological and hormonal underpinnings of stress and reward reactivity of adolescents suffering from borderline personality disorder compared to healthy adolescents by a multimodal approach based on clinical assessments, structural and functional mri and… Read more about this study

Who is it for?
Ages 13 to 18 yearsHealthy volunteers can take part
What is being tested?
Clinical assessment, Stress elicitation experiment and Structural and Functional MRI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteFrance
Study dates
4 Oct 2017to 3 Jan 2026
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Adolescent subject: 13 years ≤ age ≤ 18years
  • Affiliation to social welfare
  • Informed consent to participate in the protocol, consent signed by the major subject or by one of the legal guardians if the subject is a minor
  • Diagnosis of borderline personality disorder according to Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) and Abbreviated- Diagnostic Interview of Borderline Personality Disorder (Ab-DIB)
  • Somatic and intellectual state compatible with blood sampling and MRI examination

Who cannot join

  • Non-affiliation to social welfare
  • Refusal to give consent and / or to sign informed consent by the subject or his or her legal guardian if the subject is a minor
  • Somatic pathology in progress, or pregnancy (urine test of pregnancy in case of doubt)
  • Contraindication to magnetic resonance imaging:
  • Presence of a ferromagnetic foreign body
  • Subject carrying a pacemaker
Show all 17Show fewer
  • Subject carrying ventricular bypass valves
  • Claustrophobic topic
  • Subject suffering from the following diseases:
  • Intellectual impairment Intellectual Quotient (IQ) <70,
  • Claustrophobia,
  • Obsessive Compulsive Disorder,
  • Tic Disorder,
  • Autism Spectrum Disorder,
  • Attention Deficit Disorder with or without Hyperactivity,
  • Bipolar disorder,
  • Schizophrenia

Trial locations and contacts

1 site in 1 country.

France1 site
  • Pôle recherche clinique

    Paris, 75013

Other trials in France

About this study

Official title: Multimodal Study of the Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder : Stress Reactivity and Functional Imaging

This study aims to better understand the behavioral, neurobiological and hormonal underpinnings of stress and reward reactivity of adolescents suffering from borderline personality disorder compared to healthy adolescents by a multimodal approach based on clinical assessments, structural and functional mri and experimental acute stress exposure.

Read the detailed description

Borderline Personality Disorder (BPD) is a severe condition associated with intense emotional and behavioral responses to stressful events, impulsivity, and risk-taking behavior. It has been shown to begin in adolescence. However, very few studies have addressed the physiopathology of BPD in adolescents. In order to gather rational information for targeted care, the heterogeneity of BPD determinants needs to be disentangled. To this aim, a multimodal approach to BPD dimensional aspects is proposed.

BPD adolescents will be compared to typically developing controls in two complementary experimental designs: (1) Monitoring of neurovegetative, hormonal and body motion responses to an acute stress, with the hypothesis that stress reactivity might account for the physiopathology of the disorder; (2) Structural and functional imaging (fMRI BOLD) in the context of a reward processing task to delineate the neural/functional basis of BPD risk taking behavior.

Being tested
Clinical assessment, Stress elicitation experiment, Structural and Functional MRI, salivary collections of amylase and cortisol
Medical subject headings
Borderline Personality Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical assessmentOther

    • Self-assessments based on questionnaires : Strengths and Difficulties Questionnaire - Development and Well-Being Assessment (SDQ-DAWBA) ; Pubertal Development Scale ; Life Events Questionnaire ; Childhood Trauma Questionnaire ; Abbreviated - Diagnostic Instrument for Borderline (Ab-DIB) ; Beck Depression Inventory ; Socio-demographic questionnaire)
    • and clinical evaluation by a psychiatrist : Mini-International Neuropsychiatric Interview (MINI); Global Assessment of Functioning
  • Stress elicitation experimentBehavioural

    The stress elicitation experiment is based on a time-constrained mental arithmetic test in the presence of an observer. The task usually lasts about 30 minutes.

    During the task, the investigators will monitor: neuro-vegetative parameters (skin conductance, temperature, respiratory and cardiac frequencies, and VNA) ; biological parameters : salivary Cortisol and Amylase before test (baseline), 15 min and 30 min after testing (respectively corresponding to Reactivity and Recovery) ; micro-behavioral cues extracted from 2D video and 3D sensors (Microsoft Kinect).

  • Structural and Functional MRIOther

    Structural and Functional Magnetic Resonance Imaging (MRI). The functional acquisition will last 20 minutes and the structural acquisition 18 minutes. All MR image acquisition methodologies are already functioning on the 3 Tesla Prisma machine within the ICM(Brain and Spine Institute), Salpetriere. The fMRI session will provide three types of data: (1) task-related activity to probe the striato-limbic and prefrontal regions, (2) resting state connectivity to examine the integrity of canonical networks, and (3) MR structural images to measure regional volumes of key functional nodes.

    For the task-related fMRI study, the investigators will use the monetary incentive delay task that reliably elicit an activation in known functional networks underlying reward anticipation/outcome.

  • salivary collections of amylase and cortisolBiological

    Collection of saliva samples of cortisol and amylase repeated three times

Study groups in NCT03209102
Study groupRoleWhat they receive
BPD adolescentsExperimentalAdolescents suffering from Borderline Personality Disorder. Clinical assessment, Stress Elicitation Experiment, Structural and Functional MRI, salivary collections of amylase and cortisol
Receives: Other: Clinical assessment; Behavioral: Stress elicitation experiment; Other: Structural and Functional MRI; Biological: salivary collections of amylase and cortisol
Healthy controls adolescentsExperimentalHealthy controls adolescents. Clinical assessment, Stress Elicitation Experiment, Structural and Functional MRI, salivary collections of amylase and cortisol
Receives: Other: Clinical assessment; Behavioral: Stress elicitation experiment; Other: Structural and Functional MRI; Biological: salivary collections of amylase and cortisol

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison between subjective and objective acute stress experience in BPD Adolescents vs Healthy controls

    Comparing subjective (by self-assessment) and objective response to acute stress by measuring the biological (stress hormones and enzymes) and neurovegetative responses to stress and assessing the motor responses to stress by using novel approaches based on specific machine learning algorithms.

    Measured: up to 3 months

  2. Investigating the neural correlates and modulation of motivation and impulsivity using structural and task-based fMRI

    The fMRI session will provide three types of data: (1) task-related activity to probe the striato-limbic and prefrontal regions, (2) resting state connectivity to examine the integrity of canonical networks, and (3) MR structural images to measure regional volumes of key functional nodes. For the task-related fMRI study, the investigators will use the monetary incentive delay task that reliably elicit an activation in known functional networks underlying reward anticipation/outcome.

    Measured: up to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2017
  2. Study start4 Oct 2017
  3. Primary completion4 Oct 2024
  4. Study completion3 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03209102
Sponsor's protocol ID
C16-58
Acronym
ADOLIMIS
Status last verified
Mar 2025
First submitted
13 Jun 2017
Last updated
13 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Clinical assessment, Stress elicitation experiment and Structural and Functional MRI in people with Borderline Personality Disorder and Adolescent Development, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 13 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison between subjective and objective acute stress experience in BPD Adolescents vs Healthy controls (time frame: up to 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in